← Leaderboards
Katherine Lee McNamara
Stanford University
$135,722
Attributed
$135,722
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.3K · FY2019–22$50K$37.5K$25K$12.5K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$135,722 · 1
By mechanism
F30$135,722 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Hanlee Ji$24,780,644
- Ruijiang Li$10,760,802
- Katherine W Ferrara$45,937,231
- Samuel Strober$36,157,957
- Pasi A Janne$27,388,753
Others in their field
Other Emerging Leaders on “Evolution”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Hensley · University Of Pennsylvania$49,758,212
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- S. Mark Tompkins · University Of Georgia$20,806,329
- Walter Orenstein · Emory University$15,988,348
- Andrew Pekosz · Johns Hopkins University$15,027,681
Research focus
EvolutionFaculty MentorAffectBaseBiological MarkersAlgorithmsAftercareBreast Cancer ModelCancer GenomicsCareerCellsClinical TrialsCohortBiological ModelsBiomarker DevelopmentDedicationsDisease ProgressionDisease ResistanceDrug ResistanceDrug TargetingEducational WorkshopEffective TherapyErbb2 GeneFellowship
Grant awards (4)
Quantifying patient-specific tumor evolutionary dynamics and resistance mechanisms in HER2-positive breast cancers treated with targeted therapy$11,633
F30 · FY2022 · CA · contact PI
Quantifying patient-specific tumor evolutionary dynamics and resistance mechanisms in HER2-positive breast cancers treated with targeted therapy$42,342
F30 · FY2021 · CA · contact PI
Quantifying patient-specific tumor evolutionary dynamics and resistance mechanisms in HER2-positive breast cancers treated with targeted therapy$41,353
F30 · FY2020 · CA · contact PI
Quantifying patient-specific tumor evolutionary dynamics and resistance mechanisms in HER2-positive breast cancers treated with targeted therapy$40,394
F30 · FY2019 · CA · contact PI